搜索新闻
媒体联系

电子邮箱:id201@e-techco.com

联系电话:86-755-83209797

广西桂林领导视察易特科(前海安测)“AI医疗”

日期:2019-04-15 来源:易特科 浏览次数190316

2019年4月15日,广西壮族自治区桂林市政府副秘书长、市金融办主任高钦,科技局副局长钟可安,投资促进局副局长黄锡亮,市委组织部人才科负责人唐军,科技局发展规划科科长郑寒剑,人才服务管理办公室副主任唐伟,市委组织部干部一科科员李超,深圳市益田集团执行董事兼新兴产业集团董事长朱素萍,产业规划经理李畅一行10余人莅临易特科(前海安测)深圳研发总部考察调研AI医疗创新及产业化,洽谈战略合作!易特科集团董事长兼CEO张贯京先生率领副董事长兼MD肖应芬女士、CTO葛新科博士、总工程师高伟明博士、副总裁唐小浪先生、副总工程师张红治博士、副总工程师周亮博士、投资部融资经理霍建新先生、总裁助理陈匆女士、总裁助理杨艳铭女士等团队热情接待了考察团。


张贯京董事长首先带领考察团参观了产品展厅,详细介绍了公司发展历程、现有业务模式以及未来发展规划,张贯京董事长介绍道,目前易特科集团的主营业务主要集中在“AI+医疗+健康+养老”领域,同时,集团将按照健康中国的发展规划,顺应政府引导,把旗下的医疗信息化、健康信息化、区域卫生信息化等业务不断完善和壮大,实现打造中国智慧医疗领军企业的发展愿景。




考察团详细了解了易特科集团的规划和总体建设情况,现场体验了我司安测健康一体机、安测中医四诊仪、安测体质辨识仪等智能监测设备,实地考察了集团AI医疗云平台项目、智慧医疗诺奖实验室项目、智慧医养等项目进展,考察团赞许易特科集团智慧医疗业务发展及成长速度有目共睹,并勉励易特科坚持自主创新不动摇,积极开拓市场,争当行业楷模!



座谈会上,张贯京董事长对桂林市政府领导的信任与支持表示感谢,同时表达了愿与桂林市深度合作的诚意。张贯京董事长表示,易特科集团作为智慧医疗创新企业,一直秉承“技术引领·创新驱动”的经营理念,在全国智慧医疗领域拥有非常高的品牌影响力和极高的信誉度。易特科集团接下来也将进一步通过自主创新、与国内外众多知名高校合作等方式,研发更多更先进的医疗信息化产品和智能硬件设备,增强市场竞争力,提升社会知名度和信誉度,为全国人民提供更加优质的医疗健康服务!希望各级政府部门继续对我司科技发展和成长给予帮助、指导和支持,共同合作智慧医疗、智慧健康、智慧养老等大项目、好项目,共推智慧医疗行业高质量健康发展,为国人健康服务!



桂林市政府考察团听取汇报后表示将加大力度支持易特科集团自主研发创新发展,欢迎和支持易特科集团在桂林投资兴业,同时鼓励易特科集团抓牢健康中国转型升级机遇,尽快实现转型发展。考察团强调,要充分发挥集团已有的资源优势,拉长产业链条,扩大开放合作;要依托科技创新,加大产品力度推广应用,推动人工智能、大数据等先进科学技术在医疗、健康、养老领域的融合运用;要与时俱进、不断探索、多元发展,培育自主创新的能力和实力,以更坚定的信心、更有力的措施把智慧医疗事业不断推向深入!



The leaders of Guangxi Guilin inspected E-Techco (Qianhai AnyCheck) "AI+Medical"

On April 15th, 2019, Gao Qin, deputy secretary-general of the Guilin Municipal Government of Guangxi Zhuang Autonomous Region, director of the Municipal Finance Office, Zhong Kean, deputy director of the Science and Technology Bureau, Huang Xiliang, deputy director of the Investment Promotion Bureau, Tang Jun, head of the talent department of the Municipal Party Committee, and the Science and Technology Bureau Zheng Hanjian, Chief of Development Planning Section, Tang Wei, Deputy Director of Talent Service Management Office, Li Chao, Member of the Organization Department of the Municipal Party Committee, Zhu Suping, Executive Director of Shenzhen Yitian Group and Chairman of Xinxing Industry Group, and Li Chang, Industrial Planning Manager, visited more than 10 people. E-Techco (Qianhai AnyCheck) Shenzhen R&D Headquarters investigates and investigates AI medical innovation and industrialization, and negotiates strategic cooperation. Mr. Zhang Guanjing, Chairman and CEO of E-Techco Group, led Vice Chairman and MD Ms. Xiao Yingfen, CTO Ge Xinke, Chief Engineer Dr. Gao Weiming, Vice President Tang Xiaolang, Deputy Chief Engineer Dr. Zhang Hongzhi, Deputy Chief Engineer Dr. Zhou Liang, Investment Department Financing Mr. Huo Jianxin, president assistant Ms. Chen Cong and Ms. Yang Yanming, warmly received the delegation.

Chairman Zhang Guanjing first led the delegation to visit the product exhibition hall, detailing the company's development history, existing business model and future development plan. Chairman Zhang Guanjing introduced that the main business of E-Techco Group is mainly concentrated in “AI+Medical+Health+Elderly Care”, at the same time, the Group will follow the guidance of the government in accordance with the development plan of healthy China, and continuously improve and expand its medical information, health information, regional health information and other businesses to achieve China's smart medical leading enterprises.

The delegation learned in detail about the planning and overall construction of E-Techco Group. On the spot, we experienced intelligent monitoring equipment such as our safety and health integrated machine, the four diagnostic instruments of the Chinese medicine, and the fitness identification instrument. The field AI medical treatment was inspected. The progress of the cloud platform project, the smart medical award-winning laboratory project, and the wisdom medical care project, the delegation praised the development and growth speed of E-Techco Group's smart medical business, and encouraged E-Techco to adhere to independent innovation and actively explore the market.

At the symposium, Chairman Zhang Guanjing expressed his gratitude for the trust and support of the leaders of the Guilin Municipal Government and expressed his sincerity to cooperate with Guilin. Chairman Zhang Guanjing said that E-Techco Group, as a smart medical innovation enterprise, has been adhering to the business philosophy of “technology-led and innovation-driven” and has a very high brand influence and high credibility in the field of smart healthcare in the country. E-Techco Group will further develop more advanced medical information products and intelligent hardware devices through independent innovation and cooperation with many well-known universities at home and abroad to enhance market competitiveness and enhance social visibility and credibility. Provide better medical and health services for the people of the country. It is hoped that government departments at all levels will continue to help, guide and support the development and growth of our company's science and technology, and jointly cooperate with smart medical, smart health, smart old-age projects and other large projects, and promote the high-quality and healthy development of the smart medical industry for the health of Chinese.

After hearing the report, Guilin Municipal Government delegation said that it will increase its efforts to support E-Techco Group's independent research and development and innovation, welcome and support E-Techco Group to invest in Guilin, and encourage E-Techco Group to seize the opportunity of healthy China's transformation and upgrading as soon as possible. The delegation stressed that it is necessary to give full play to the existing resource advantages of the Group, lengthen the industrial chain and expand open cooperation; rely on technological innovation, increase product promotion and application, and promote advanced science and technology such as artificial intelligence and big data in medical care, health, and The integration and application of the old-age field; we must keep pace with the times, continue to explore, diversify, cultivate the ability and strength of independent innovation, and push the smart medical cause to a deeper level with more firm confidence and more powerful measures.